GLP-1 Side Effect Comparison Chart: Semaglutide vs Tirzepatide vs Retatrutide
Visual comparison of side effect rates across all GLP-1 medications. Data-driven chart showing nausea, vomiting, diarrhea, and other side effects by medication and dose.
More on Data Visualization
Data Summary
All GLP-1 medications share similar GI side effects that are typically mild and transient. Only 4-7% of patients discontinue treatment. Proper dose titration significantly reduces side effect severity.
Side Effect Rates by Medication
| Side Effect | Semaglutide | Tirzepatide | Retatrutide | Typical Severity |
|---|---|---|---|---|
| Nausea | 44% | 25-33% | 33% | Mild-Moderate |
| Diarrhea | 30% | 21-25% | 22% | Mild |
| Vomiting | 24% | 9-13% | 17% | Mild-Moderate |
| Constipation | 24% | 14-17% | 18% | Mild |
| Abdominal Pain | 20% | 8-14% | 12% | Mild |
| Headache | 14% | 8-10% | 10% | Mild |
| Fatigue | 11% | 5-7% | 8% | Mild |
| Injection Site Reaction | 3% | 3-5% | 5% | Mild |
Data from highest approved/studied doses. Rates at lower starting doses are significantly lower. Sources: STEP, SURMOUNT, and Phase 2 retatrutide trials.
Understanding the Data
Good News
- Most side effects resolve within 4-8 weeks
- Slow titration reduces severity by 40-60%
- Serious side effects are rare (under 1%)
- 93-96% of patients continue treatment
Management Strategies
- Eat small, frequent meals to reduce nausea
- Stay well hydrated (80+ oz water daily)
- Take fiber supplements for constipation
- Contact your provider if side effects persist beyond 2 weeks
Medical Disclaimer: This data represents clinical trial averages. Individual experiences vary. Report severe or persistent side effects to your healthcare provider immediately.
Frequently Asked Questions
Which GLP-1 has the fewest side effects?
At equivalent weight-loss-producing doses, side effect profiles are similar across GLP-1 medications. Tirzepatide may have slightly lower nausea rates than semaglutide at comparable efficacy. Most side effects are GI-related and diminish over 4-8 weeks as the body adjusts.
How common is nausea on GLP-1 medications?
Nausea occurs in approximately 40-44% of semaglutide patients and 25-33% of tirzepatide patients during dose titration. It is usually mild to moderate and transient, resolving within the first month at each dose level. Only 4-7% of patients discontinue due to side effects.
Do side effects get worse at higher doses?
Side effects can temporarily increase with each dose escalation. Slow titration (staying at each dose for 4+ weeks) significantly reduces side effect severity. Most patients tolerate higher doses well after the initial adjustment period.
What percentage of patients stop treatment due to side effects?
Across clinical trials, 4-7% of patients discontinue GLP-1 medications due to adverse events. This is remarkably low given the significant weight loss benefits. Proper titration and side effect management reduce discontinuation rates further.
Expert-Guided GLP-1 Treatment
Compounded semaglutide from $99/mo or tirzepatide from $125/mo with side effect management support.
View Treatment Options